Recombinant human granulocyte colony stimulating factor versus bone marrow mononuclear cells in treatment of pulmonary emphysema model
Conclusion These results indicate nearly similar effectiveness of both filgrastim and BMMNCs in treatment of lipopolysaccharide induced pulmonary emphysema.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
More News: Egypt Health | Emphysema | Filgrastim | Gastroschisis Repair | Neulasta | Neupogen | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Study | Tuberculosis